Hunan Fangsheng Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -6.14% vs 17.66% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 135.66% vs -62.29% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "462.80",
          "val2": "493.10",
          "chgp": "-6.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "102.20",
          "val2": "83.60",
          "chgp": "22.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.30",
          "val2": "3.10",
          "chgp": "-25.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-3.80",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "87.90",
          "val2": "37.30",
          "chgp": "135.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "220.80%",
          "val2": "125.60%",
          "chgp": "9.52%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -1.88% vs 9.17% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 21.14% vs 39.09% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,728.00",
          "val2": "1,761.10",
          "chgp": "-1.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "390.60",
          "val2": "324.10",
          "chgp": "20.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "15.00",
          "val2": "22.10",
          "chgp": "-32.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.90",
          "val2": "-11.50",
          "chgp": "107.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "302.60",
          "val2": "249.80",
          "chgp": "21.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "175.90%",
          "val2": "135.80%",
          "chgp": "4.01%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

462.80

493.10

-6.14%

Operating Profit (PBDIT) excl Other Income

102.20

83.60

22.25%

Interest

2.30

3.10

-25.81%

Exceptional Items

0.00

-3.80

100.00%

Consolidate Net Profit

87.90

37.30

135.66%

Operating Profit Margin (Excl OI)

220.80%

125.60%

9.52%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -6.14% vs 17.66% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 135.66% vs -62.29% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,728.00

1,761.10

-1.88%

Operating Profit (PBDIT) excl Other Income

390.60

324.10

20.52%

Interest

15.00

22.10

-32.13%

Exceptional Items

0.90

-11.50

107.83%

Consolidate Net Profit

302.60

249.80

21.14%

Operating Profit Margin (Excl OI)

175.90%

135.80%

4.01%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -1.88% vs 9.17% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 21.14% vs 39.09% in Dec 2024

All Annual Results